HOME >> BIOLOGY >> NEWS
Popular Science outlines need for long-term studies and more regulation in A.R.T.

America Online to Carry Article Exclusively and Will Host Online Chat on Tuesday, February 11 at 8pm EST

New York, NY, February 6, 2003 -- In an article in its March issue (on newsstands February 11), Popular Science magazine describes the need for long-term studies and more regulation in assisted reproductive technology (ART). The article "Sallie has 2 Mommies & 1 Daddy," explores the science behind the risks of ART and the problems with the U.S. regulatory system that have allowed untested technologies to be used on patients for decades without oversight.

One in 11 couples in the United States is infertile. Desperation to have a child is widespread. Each year, thousands of these couples expose themselves and their future children to dangerous fertility treatments that were rushed from petri dishes to patients without regulation or human trials. About a million children have been born using assisted reproductive technology-otherwise known as ART-which has become so advanced, couples using it are statistically more likely to conceive a child than those relying on the old-fashioned natural approach.

The recent claim that a fringe group had cloned a human caused yet another wave of protests from scientists and politicians over reproductive cloning. It'll cause birth defects, they said, it'll create children with unimaginable problems. But with the spotlight on cloning, Americans missed one important point: For decades, fertility clinics have been doing precisely what scares experts about cloning. By using unregulated technologies on patients, they're creating children through experimental procedures with well-documented and potentially widespread risks. PopSci magazine's article examines and discusses the need for regulation and increased research into fertility methods.

The complete story can be found exclusively on AOL in the Health Channel (Keyword: Health Poll) beginning on February 6. Beginning on Monday, Feb
'"/>

Contact: Sara Delekta
sara.delekta@time4.com
917-868-4502
Popular Science
6-Feb-2003


Page: 1 2

Related biology news :

1. Popular Science announces Third Annual Brilliant 10
2. Popular Science announces second annual Brilliant 10: the countrys top young scientists
3. Popularizing precision agriculture
4. Popular weed killer feminizes native leopard frogs across Midwest
5. Popular weed killer disrupts frogs sexual development
6. Popular weed killer demasculinizes frogs, disrupts their sexual development
7. Popular pain analgesics found to affect central nervous system: Study identifies both peripheral and CNS mechanisms of action of NSAID use
8. Popular Diet Supplement May Be A Cancer Risk
9. Emu Meat Not A Popular Choice Among Consumers, Study Shows
10. New Studies Shed Light On Facial Features Of Popular Dinosaurs
11. Popular Cure-All Tea Can Cause Toxic Reactions

Post Your Comments:
(Date:1/22/2015)...  Today, FreeWavz ( www.FreeWavz.com ), the developer of ... Fundable, https://www.fundable.com/freewavz . FreeWavz will be expanding ... meet customer demand. Logo - ... Invented by Dr. Eric ...
(Date:1/22/2015)... 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... on the recent success of the Wocket™ smart wallet at CES 2015 ... wallet was named as one of the "11 Hot Products at CES" ... Launched At CES So Far" by Newseveryday.com and "The top 10 gadgets ...
(Date:1/22/2015)... Research and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ) ... Wearable Technologies Market and Applications, Opportunities, Industry Analysis, ... 2014-2020" report to their offering. , ... can be worn on the user,s body and ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2
(Date:1/22/2015)... Pipette.com has added the Eppendorf ... portfolio of Eppendorf products. , The Eppendorf Centrifuge 5424/5424 ... 5424/5424 R and receive the following:, , ... or Eppendorf Reference 2 ,     3 Free ...
(Date:1/22/2015)... Switzerland (PRWEB) January 22, 2015 Selexis ... characterized mammalian Research Cell Banks (RCBs) used for drug ... Research Cell Banks will include Next-Generation Sequencing ... genetic architecture de-risks biologic manufacturing by ensuring the integrity ...
(Date:1/22/2015)... Medical Systems (NYSE: VAR ), world leader in ... to sustainability with inclusion on a prestigious list of the ... equipment company among the Corporate Knights Global 100 Most Sustainable ... Davos, Switzerland . "We ...
(Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... (NYSE: MDT ) has submitted a pre-market ... (FDA) for the use of Medtronic,s SynchroMed ® ... catheter) for use with United Therapeutics, Remodulin ® ...
Breaking Biology Technology:Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
Cached News: